Heart failure (HF) is the leading cause of mortality in patients with acute myocardial
infarction (AMI), with incidence ranging from 14% to 36% in patients admitted due to AMI. HF …

The survival of ischaemic cardiomyocytes after myocardial infarction (MI) depends on the
formation of new blood vessels. However, endogenous neovascularization is inefficient and …

Since ischemic heart disease (IHD) is a major cause of mortality and heart failure, novel
therapeutic strategies are expected to improve the clinical outcomes of patients with acute …

Depending on their concentrations, both nitric oxide (NO) and reactive oxygen species
(ROS) take part either in myocardial ischemia reperfusion injury or in protection by ischemic …

BACKGROUND: Intestinal ischemia-reperfusion (I/R) is a potentially life-threatening
situation and its pathomechanism is not fully understood yet. OBJECTIVE: To investigate the …

Microvascular obstruction is a common repercussion of percutaneous coronary intervention
for distal microembolization, ischemia–reperfusion injury and inflammation, which increases …

Background We investigated the potential of telmisartan to improve microvascular
dysfunction induced by myocardial ischemia/reperfusion (I/R) injury by activating the …

Background Edema is present in many heart diseases, and differentiation between
intracellular (ICW) and extracellular (ECW) myocardial water compartments would be …

Neovascularization of the ischemic myocardium postinfarction is necessary to restore blood
flow to vulnerable cardiomyocytes and will be indispensable for prospective regenerative …

We prospectively studied the correlations between plasma levels of von Willebrand factor
and its cleaving protease—a disintegrin and metalloproteinase with thrombospondin type I …